Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 94.83 M76.55 M75.43 M96.87 M 343.69 M Research & development ———— — Operating income 64.92 M104.26 M92.05 M64.02 M 325.25 M Non-Operating Income, Total 3.35 M2.58 M2.73 M2.32 M 10.98 M Interest expense, net of interest capitalized 34.11 M30.95 M31.54 M32.5 M 129.1 M Non-Operating Income, excl. Interest Expenses -34.11 M-30.95 M-31.54 M-32.5 M -129.1 M Unusual income/expense 3.35 M2.58 M2.73 M2.32 M 10.98 M Pretax income 34.16 M75.9 M63.24 M33.19 M 206.49 M Equity in earnings ———— — Taxes 11.45 M20.79 M18.98 M6.71 M 57.94 M Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations 22.71 M55.11 M44.25 M26.48 M 148.56 M Discontinued operations ———— — Net income 22.71 M55.11 M44.25 M26.48 M 148.56 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 22.71 M55.11 M44.25 M26.48 M 148.56 M Basic earnings per share (Basic EPS) 0.120.290.230.13 0.77 Diluted earnings per share (Diluted EPS) 0.120.290.230.14 0.78 Average basic shares outstanding 190.29 M191.95 M190.79 M193.41 M — Diluted shares outstanding 190.9 M192.71 M191.25 M194.03 M — EBITDA 105.5 M141.25 M130.44 M104.31 M 481.5 M EBIT 64.92 M104.26 M92.05 M64.02 M 325.25 M Cost of revenue 201.05 M196.52 M204.26 M202.78 M 804.6 M Other cost of goods sold ———— — Depreciation & amortization (cash flow) 40.58 M36.99 M38.39 M40.29 M 156.25 M